Ye, Jianbin
Liu, Qiaoyuan
He, Yunxuan
Song, Zhenkun
Lin, Bao
Hu, Zhiwei
Hu, Juanyuan
Ning, Yunshan
Cai, Cheguo
Funding for this research was provided by:
National Natural Science Foundation of China (81971903)
National Key R&D Program of China, Synthetic Biology Research (2019YFA0903802)
Basic and Applied basic Research Project of Guangdong Province (2023A1515010084)
Article History
Received: 2 November 2023
Accepted: 12 February 2024
First Online: 18 February 2024
Declarations
:
: Peripheral blood mononuclear cells (PBMC) from healthy donors were purchased from Milestone Biotechnologies (Shanghai, China) and handled with necessary safety procedures and ethical requirements. All animal protocols were approved by the Institutional Human Ethics Review Board of Southern Medical University, China.
: Not applicable.
: The authors declare that they have no competing interests.